Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Page 1
[Risk of epilepsy after a first epileptic seizure with unknown etiology in elderly patients].
López-Maza S, Abraira L, Bellido-Castillo E, Lallana S, Campos-Fernández D, Fonseca E, Quintana M, Santamarina E, Rovira A, Sarria-Estrada S, Toledo-Argany M. López-Maza S, et al. Among authors: quintana m. Rev Neurol. 2024 May 16;78(10):277-283. doi: 10.33588/rn.7810.2024055. Rev Neurol. 2024. PMID: 38743021 Spanish.
The aim is to clinically characterise these patients, and predict their risk of developing epilepsy in the long term. MATERIALS AND METHODS: This is a retrospective observational study of patients over 55 years old experiencing a first epileptic seizure with unknown etiolo …
The aim is to clinically characterise these patients, and predict their risk of developing epilepsy in the long term. MATERIALS AND M …
[Position statement for improvement in reperfusion of ST-elevation myocardial infarction in Latin America].
Costabel JP, Quintana M, Perea J, Lamelas P, Candiello A, Sanhueza P, Arias-Mendoza A, Saavedra I, Rivera-Toquica A, de Castro ML, Álvarez-Gaviria M, Belardi J, Cequier Á, Sosa-Liprandi Á, Villarreal R. Costabel JP, et al. Among authors: quintana m. Arch Cardiol Mex. 2024 Jan 16;94(2):208-218. doi: 10.24875/ACM.23000045. Arch Cardiol Mex. 2024. PMID: 38227853 Free article. Spanish.
In Latin America, national myocardial infarction treatment programs should focus on improving outcomes, and long-term success depends on working toward defined goals and enhancing functionality, therefore programs should develop capacity to measure their performance. ...
In Latin America, national myocardial infarction treatment programs should focus on improving outcomes, and long-term success depends …
Risk assessment of long-term epilepsy after de novo status epilepticus with clinical and electroencephalographic biomarkers: The AFTER score.
Rodrigo-Gisbert M, Abraira L, Quintana M, Gómez-Dabó L, López-Maza S, Sueiras M, Thonon V, Campos-Fernández D, Lallana S, Fonseca E, Toledo M, Santamarina E. Rodrigo-Gisbert M, et al. Among authors: quintana m. Epilepsy Behav. 2023 Dec;149:109531. doi: 10.1016/j.yebeh.2023.109531. Epub 2023 Nov 22. Epilepsy Behav. 2023. PMID: 37995538
The individualized management of patients with high risk of subsequent epilepsy could improve long-term quality of life and cognitive impairment. We aimed to ascertain potential biomarkers of subsequent epilepsy and to construct a scoring system possessing predictive value …
The individualized management of patients with high risk of subsequent epilepsy could improve long-term quality of life and cognitive …
Prediction of long-term unprovoked seizures after status epilepticus.
Rodrigo-Gisbert M, Gómez-Dabó L, Quintana M, Campos-Fernández D, Lallana S, Fonseca E, Abraira L, Toledo M, Santamarina E. Rodrigo-Gisbert M, et al. Among authors: quintana m. Epilepsia. 2023 Sep;64(9):2399-2408. doi: 10.1111/epi.17697. Epub 2023 Jul 6. Epilepsia. 2023. PMID: 37347842
OBJECTIVE: Possible long-term consequences of status epilepticus (SE) include cognitive and behavioral impairment and the development of chronic epilepsy. However, these aspects have not been systematically studied in clinical practice. We aimed to evaluate long-term …
OBJECTIVE: Possible long-term consequences of status epilepticus (SE) include cognitive and behavioral impairment and the development …
Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography.
Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I, Quintana MJ, Alcántara R, Saladié F, Del Riego J, Peñalva L, Sala M, Castells X, On Behalf Of The Bele And Iris Study Groups. Román M, et al. Among authors: quintana mj. Int J Environ Res Public Health. 2022 Feb 24;19(5):2625. doi: 10.3390/ijerph19052625. Int J Environ Res Public Health. 2022. PMID: 35270331 Free PMC article.
Assessing the long-term risk of breast cancer after diagnosis of benign breast disease by mammography is of utmost importance to design personalised screening strategies. ...The relative risk increased to 1.99 among women followed for less than four years, and remained ele …
Assessing the long-term risk of breast cancer after diagnosis of benign breast disease by mammography is of utmost importance to desi …
Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
Guisier F, Deslee G, Birembaut P, Escarguel B, Chapel F, Bota S, Métayer J, Lachkar S, Capron F, Homasson JP, Taulelle M, Quintana M, Raspaud C, Messelet D, Benzaquen J, Hofman P, Baddredine J, Paris C, Cales V, Laurent P, Vignaud JM, Ménard O, Copin MC, Ramon P, Bouchindhomme B, Tavernier JY, Quintin I, Quiot JJ, Galateau-Sallé F, Zalcman G, Piton N, Thiberville L. Guisier F, et al. Among authors: quintana m. Eur Respir J. 2022 Sep 15;60(3):2101946. doi: 10.1183/13993003.01946-2021. Print 2022 Sep. Eur Respir J. 2022. PMID: 35236723 Free article. Clinical Trial.
After baseline lung computed tomography (CT) and autofluorescence bronchoscopy (AFB) to exclude lung cancer and bronchial severe squamous dysplasia or carcinoma in situ (CIS), patients were assigned to standard surveillance (arm A) with CT and AFB at 36 months or to intensive sur …
After baseline lung computed tomography (CT) and autofluorescence bronchoscopy (AFB) to exclude lung cancer and bronchial severe squamous dy …
Attending guidance advised: educational quality of surgical videos on YouTube.
Jackson HT, Hung CS, Potarazu D, Habboosh N, DeAngelis EJ, Amdur RL, Estroff JM, Quintana MT, Lin P, Vaziri K, Lee J. Jackson HT, et al. Among authors: quintana mt. Surg Endosc. 2022 Jun;36(6):4189-4198. doi: 10.1007/s00464-021-08751-0. Epub 2021 Oct 19. Surg Endosc. 2022. PMID: 34668066
METHODS: An incognito search was conducted on YouTube using the term "laparoscopic cholecystectomy." Results were screened for length, publication date, and language. ...
METHODS: An incognito search was conducted on YouTube using the term "laparoscopic cholecystectomy." Results were screened for length …
Magnetic resonance imaging findings in focal-onset status epilepticus.
Sarria-Estrada S, Santamarina E, Quintana M, Pareto D, Sueiras M, Auger C, Toledo M, Rovira A. Sarria-Estrada S, et al. Among authors: quintana m. Eur J Neurol. 2022 Jan;29(1):3-11. doi: 10.1111/ene.15065. Epub 2021 Sep 3. Eur J Neurol. 2022. PMID: 34390102
The purpose of this study was to characterize MRI features in SE patients and determine their association with clinical and electroencephalography (EEG) findings. The mid-term consequences of baseline MRI features were also analysed. METHODS: This is a prospective study in …
The purpose of this study was to characterize MRI features in SE patients and determine their association with clinical and electroencephalo …
Testing a global standard for quantifying species recovery and assessing conservation impact.
Grace MK, Akçakaya HR, Bennett EL, Brooks TM, Heath A, Hedges S, Hilton-Taylor C, Hoffmann M, Hochkirch A, Jenkins R, Keith DA, Long B, Mallon DP, Meijaard E, Milner-Gulland EJ, Rodriguez JP, Stephenson PJ, Stuart SN, Young RP, Acebes P, Alfaro-Shigueto J, Alvarez-Clare S, Andriantsimanarilafy RR, Arbetman M, Azat C, Bacchetta G, Badola R, Barcelos LMD, Barreiros JP, Basak S, Berger DJ, Bhattacharyya S, Bino G, Borges PAV, Boughton RK, Brockmann HJ, Buckley HL, Burfield IJ, Burton J, Camacho-Badani T, Cano-Alonso LS, Carmichael RH, Carrero C, Carroll JP, Catsadorakis G, Chapple DG, Chapron G, Chowdhury GW, Claassens L, Cogoni D, Constantine R, Craig CA, Cunningham AA, Dahal N, Daltry JC, Das GC, Dasgupta N, Davey A, Davies K, Develey P, Elangovan V, Fairclough D, Febbraro MD, Fenu G, Fernandes FM, Fernandez EP, Finucci B, Földesi R, Foley CM, Ford M, Forstner MRJ, García N, Garcia-Sandoval R, Gardner PC, Garibay-Orijel R, Gatan-Balbas M, Gauto I, Ghazi MGU, Godfrey SS, Gollock M, González BA, Grant TD, Gray T, Gregory AJ, van Grunsven RHA, Gryzenhout M, Guernsey NC, Gupta G, Hagen C, Hagen CA, Hall MB, Hallerman E, Hare K, Hart T, Hartdegen R, Harvey-Brown Y, Hatfield R, Hawke T, … See abstract for full author list ➔ Grace MK, et al. Among authors: quintana mg. Conserv Biol. 2021 Dec;35(6):1833-1849. doi: 10.1111/cobi.13756. Epub 2021 Jul 21. Conserv Biol. 2021. PMID: 34289517
Based on our results, we devised an updated assessment framework that introduces the option of using a dynamic baseline to assess future impacts of conservation over the short term to avoid misleading results which were generated in a small number of cases, and redefines s …
Based on our results, we devised an updated assessment framework that introduces the option of using a dynamic baseline to assess future imp …
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study.
Carrillo N, Malicdan MC, Leoyklang P, Shrader JA, Joe G, Slota C, Perreault J, Heiss JD, Class B, Liu CY, Bradley K, Jodarski C, Ciccone C, Driscoll C, Parks R, Van Wart S, Bayman L, Coffey CS, Quintana M, Berry SM, Huizing M, Gahl WA. Carrillo N, et al. Among authors: quintana m. Genet Med. 2021 Nov;23(11):2067-2075. doi: 10.1038/s41436-021-01259-x. Epub 2021 Jul 13. Genet Med. 2021. PMID: 34257421 Free PMC article. Clinical Trial.
Decreased disease progression was estimated at 12 (gamma = 0.61 [95% CI: 0.09, 1.27]) and 18 months (gamma = 0.55 [95% CI: 0.12, 1.02]) using the GNE-DPM. CONCLUSION: ManNAc showed long-term safety, biochemical efficacy consistent with the intended mechanism of action, and …
Decreased disease progression was estimated at 12 (gamma = 0.61 [95% CI: 0.09, 1.27]) and 18 months (gamma = 0.55 [95% CI: 0.12, 1.02]) usin …
61 results